Dublin, Sept. 02, 2021 (GLOBE NEWSWIRE) -- The "Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
The global genomics market exhibited strong growth during 2015-2020. Genomics refers to the study of the structure, function and inheritance of the genetic material present in the deoxyribonucleic acid (DNA) of an organism. It addresses the intrarelationship of all genes to identify their combined influence on the overall growth and development. It involves various consumables, systems, software and services for diagnostics, drug discovery, development of precision medicine and agricultural research. Some of the technologies used for genomics include microarray, sequencing, polymerase chain reaction (PCR), nucleic acid extraction and purification and single-cell genomics analysis. These techniques are highly effective in solving complex genetic problems.
The increasing adoption of non-invasive cancer screening-based research, along with the growing demand for personalized medicines, is one of the key factors driving the growth of the market. Furthermore, the rising incidences of chronic diseases is also providing a boost to the market growth. Clinical workflows are widely being integrated with genomic data for the production of targeted and personalized medicines and for studying the growth of newborn genetic screening programs and military genomics. This, along with the growing demand for genetically modified plants and organisms in the agriculture sector, is creating a positive impact on the market growth. Various technological advancements, including the development of genomics-based apps and tests, are acting as another major growth-inducing factor. Other factors, such as extensive research and development (R&D) activities in the field of bioinformatics and the increasing demand for next-generation sequencing services, are projected to drive the market further. Looking forward, the publisher expects the global genomics market to grow at a CAGR of around 16% during the forecast period (2021-2026).
Breakup by Component:
- Products
- Instruments and Software
- Consumables and Reagents
- Services
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
- Others
Breakup by Application:
- Functional Genomics
- Epigenomics
- Biomarkers Discovery
- Pathway Analysis
- Others
Breakup by Technology:
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
- Others
Breakup by End-User:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being 23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG, Thermo Fisher Scientific Inc., etc.
Key Questions Answered in This Report:
- How has the global genomics market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global genomics market?
- What is the breakup of the market based on the component?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global genomics market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Genomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Products
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Instruments and Software
6.1.2.2 Consumables and Reagents
6.1.3 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Core Genomics Services
6.2.2.2 NGS-Based Services
6.2.2.3 Biomarker Translation Services
6.2.2.4 Computational Services
6.2.2.5 Others
6.2.3 Market Forecast
7 Market Breakup by Application
7.1 Functional Genomics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epigenomics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biomarkers Discovery
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pathway Analysis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Technology
8.1 Sequencing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Microarray
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Polymerase Chain Reaction
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nucleic Acid Extraction and Purification
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End-User
9.1 Research Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
14 Price Indicators
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 23andMe, Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Agilent Technologies, Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer Aktiengesellschaft
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 BGI Genomics Co. Ltd.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Bio-RAD Laboratories Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Danaher Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Illumina Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Oxford Nanopore Technologies
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 PerkinElmer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Myriad Genetics Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Roche Holding AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/8f9nu9
